Sunscreens in the United States might soon be able to include a new ingredient.

In addition, FDA agreed to submit to the district court and to the NRDC status reports every 6 months (until each monograph is completed) containing a description of the actions taken by FDA to meet ...

This proposal marks a historic milestone as it follows the first-ever Tier 1 OTC Monograph Order Request (OMOR) to be submitted to FDA – by dsm-firmenich - to amend OTC Monograph M020 and permit PARSO ...

Based on the data reviewed by the FDA, bemotrizinol provides protection against both ultraviolet A and B rays, has low levels ...

The Food and Drug Administration (FDA) has issued a proposed rule requesting additional scientific data to support the safety and efficacy of certain ingredients in antiseptics used in healthcare and ...

On Thursday the Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter monograph drug products for the ...

Please provide your email address to receive an email when new articles are posted on . An FDA review found that oral phenylephrine is not effective in treating nasal congestion. The proposal is based ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

WASHINGTON (AP) - The Food and Drug Administration is seeking to revamp its system for regulating hundreds of over-the-counter drugs, saying the decades-old process is not flexible enough to keep pace ...

The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not "generally ...